Jeff Jochims

Chief Executive Officer

25+ years of leadership in the life sciences and healthcare industries, including long executive tenures at industry leaders Thermo Fisher Scienfic and Owens & Minor. Mr. Jochims has deep experience in entrepreneurial start-ups as well as global life sciences and healthcare companies of all sizes. Businesses under Jochims’ influence have consistently delivered customer-centric operational excellence and market share gains.

C-suite Officer at NYSE:OMI (COO) & 15 years as an executive leader at NYSE:TMO (Global President, Fisher Scientific). Educ: JD (U of Pittsburgh) & BA (U of Illinois).

Dr. Ilker Bayer

Chief Scientist

Dr. Bayer completed his doctoral studies in chemical engineering at the University of Illinois, where his research concentrated on the interactions between surfaces and liquids, as well as interface science. He was a visiting and post-doctoral researcher in the Mechanical and Aerospace Engineering Departments at both the University of Illinois and the University of Virginia. Subsequently, Dr. Bayer served as a research scientist at the Italian Institute of Technology (iit) for fifteen years. He holds the position of visiting professor at the University of Virginia.

Dr. Bayer's research endeavors primarily revolve around functional coatings, hybrid nanomaterials, controlled drug release, and the development of bio-based polymer composites for applications in biomedical engineering. According to Google Scholar his h-index is 62 and Dr. Bayer has been involved in the filing and granting of thirty patents, demonstrating his innovative approach and commitment to advancing scientific knowledge and technological advancements

Dr. Eugene Duan

Analytical Chemist

Dr. Duan's focus is on iodine technological research and product developments in the fields of dermatology, medical devices, medicine, and agricultural as well as aquacultural disinfectants. Before joining I2Pure, Dr. Duan served as a consultant for several companies in product research and marketing.

Dr. Duan founded and was a co-partner in three companies in China with a focus in the fields of agriculture and aquaculture, medical devices, and pharmaceuticals. He held various positions including legal representative, chair of board, president, vice president or chief technology officer, with these firms. He was with Symbollon Pharmaceuticals as a senior scientist and later as director of the research and development department from 1994 to 2002. He has authored over a dozen publications and patents and obtained various degrees and awards.

Dr. Jack Kessler

Chief Scientific Officer

World-renowned scientist on molecular iodine technology. Past senior scientist at Hoffman-LaRoche & senior principal systems engineer at Elbit Systems of America. He was senior scientist in new technology evaluation at Hoffman-LaRoche, before becoming senior principal systems engineer at Elbit Systems of America. Kessler is a member of the founding team of Symbollon Pharmaceuticals, Iotech International, and I2Pure, where he is Chief Science Officer.

Dr. Victor Nizet

Chief Medical Officer

Dr. Nizet is a professor of Pediatrics, Vice Chair for Basic Research, and Chief of the Division of Host-Microbe Systems & Therapeutics at the University of California, San Diego (UCSD) School of Medicine. He is also a professor at UCSD Skaggs School of Pharmacy & Pharmaceutical Sciences. He has authored over 520 peer-reviewed publications and has collaborated with biotechnology professionals in developing new antibiotic and immune-based therapies or vaccines.

At UC San Diego, he leads a large basic and translational research laboratory studying bacterial pathogenesis, innate immunity, and novel approaches to the treatment of antibiotic-resistant pathogens and sepsis.

Dr. Peter Johnston

Orthopedics Advisor

Dr. Johnston, is an orthopedic surgeon whose passion is driven by the care and treatment of patients with shoulder and elbow conditions.

He is currently in private practice at the Centers for Advanced Orthopedics, serves as an Associate Professor of Orthopedic Surgery at Georgetown University teaching the latest techniques in shoulder and elbow surgery, and is a member of the fellowship faculty at Medstar Union Memorial Hospital mentoring future shoulder and elbow specialists. He was awarded a fellowship at the prestigious Rothman Institute at Thomas Jefferson University. Here he worked with world leaders in the field of shoulder and elbow surgery, and refined his skills in complex shoulder replacement, instability, and rotator cuff repair. After completing his fellowship, he furthered his knowledge of shoulder replacement in France working with master surgeons specifically focused on reverse shoulder replacement.

He is an active society member in the American Shoulder Elbow Surgeons, has numerous publications in peer-reviewed journals and textbooks, and has presented at national and international conferences. He is involved in multiple collaborative research efforts to further the understanding of the natural history of shoulder replacement and functional outcomes that allow a return to sport. He has served abroad as a primary investigator in an Investigational Device Exemption study - to evaluate the efficacy and safety of a new bearing surface for partial shoulder replacement for young active patients with severe arthritis. Dr. Johnston carries multiple patents.

Doug Spitz

Executive Chair of the Board

For over 25 years, Mr. Spitz has specialized in delivering solutions that feature emerging and innovative technologies.

He is a past board member of the World Iodine Association in Brussels. Prior to I2Pure, he was the President of PerformanceNet Management Group. PerformanceNet delivered a broad spectrum of emerging, innovative technologies to the U.S. federal government.

Mr. Spitz served in the U.S. Army for eight years in both active and reserve officer posts in the Chemical Corps.

Joe Steinberg

Currently the Chair of Jefferies Financial Group, Mr. Steinberg has been a Director and President here since 1979.

He has led and served on the board of eleven different companies. From 1979 to 2013, Mr. Steinberg served as President of Leucadia National Corporation. He is Chairman of the Board of Directors at St. Ann’s Center for Arts and Education located in New York’s Brooklyn DUMBO (Down Under the Manhattan Bridge Overpass) district, a Trustee of New York University, and serves on the boards of several nonprofit organizations.

Jeff Jochims

Chief Executive Officer

25+ years of leadership in the life sciences and healthcare industries, including long executive tenures at industry leaders Thermo Fisher Scienfic and Owens & Minor. Mr. Jochims has deep experience in entrepreneurial start-ups as well as global life sciences and healthcare companies of all sizes. Businesses under Jochims’ influence have consistently delivered customer-centric operational excellence and market share gains.

C-suite Officer at NYSE:OMI (COO) & 15 years as an executive leader at NYSE:TMO (Global President, Fisher Scientific).

Dr. Jack Kessler

Chief Scientific Officer

World-renowned scientist on molecular iodine technology. Past senior scientist at Hoffman-LaRoche & senior principal systems engineer at Elbit Systems of America. He was senior scientist in new technology evaluation at Hoffman-LaRoche, before becoming senior principal systems engineer at Elbit Systems of America. Kessler is a member of the founding team of Symbollon Pharmaceuticals, Iotech International, and I2Pure, where he is Chief Science Officer.

Lee Larson

Lee has been a leader in the investment industry for 16 years and held prior positions such as Fund Manager under Fundamental Global and Senior Vice President with Capital Wealth Advisors. Lee serves on the boards of 27 Software U.S. Inc. d/b/a DXterity Solutions, True Health Solutions Inc., and Beacon Health Benefits Inc.